|
03 Aug 2007 |
Unigene Initiates Oral Calcitonin Clinical Study in Humans
|
|
02 Aug 2007 |
Lev Pharmaceuticals Submits Biologics License Application for Cinryze(TM)
|
|
01 Aug 2007 |
Laureate Pharma Announces Agreement with Enobia Pharma, Inc.
|
|
31 Jul 2007 |
Cadence Pharmaceuticals announces agreement with fda on increased enrolment in Phase III clinical trial of Omigard (TM)
|
|
28 Jul 2007 |
OSI Pharmaceuticals Announces Agreement to Divest Anti-Platelet Derived Growth Factor (PDGF) Program
|
|
27 Jul 2007 |
OctoPlus announces promising results for Locteron Phase IIa clinical study
|
|
27 Jul 2007 |
Mircera approved in European Union for treatment of anaemia related to chronic kidney disease
|
|
25 Jul 2007 |
The Journal of Hand Surgery Publishes Initial Phase III Data on XIAFLEX(TM) (formerly known as AA4500), Auxilium's Investigational Treatment for Patients with Dupuytren's Contracture
|
|
24 Jul 2007 |
SYGNIS successfully completes clinical study IIa for AX200 in stroke (AXIS)
|
|
21 Jul 2007 |
Yondelis (R) receives positive opinion in europe for the treatment of soft tissue sarcoma
|
|
21 Jul 2007 |
BioXell to regain rights to TREM platform following strategic decision by Merck & Co., Inc.
|
|
20 Jul 2007 |
Abraxis BioScience and Biocon Limited Announce Licensing Agreement for G-CSF in North America and the European Union
|
|
20 Jul 2007 |
Tercica Completes Enrollment of Clinical Trial MS301 Evaluating Treatment with Increlex in Children with Primary IGFD
|
|
20 Jul 2007 |
Bone Medical Phase II Capsitonin(TM) (oral calcitonin)
|
|
18 Jul 2007 |
Ambrilia Completes Korean Licensing Partnership with Shin Poong for its Long-Acting Formulation of Octreotide
|
|
18 Jul 2007 |
CVBT Announces Positive Pre-Clinical Results for Protein-Based Drug Candidate to Treat Osteoporosis
|
|
17 Jul 2007 |
Affymax(R) Announces Phase 3 Development Plan for Hematide(TM)
|
|
17 Jul 2007 |
NPS Pharmaceuticals Announces Sale of Preotact(R) Royalty to Drug Royalty Corporation (DRC)
|
|
14 Jul 2007 |
Biolex Therapeutics Presents Preclinical Results for Clot Buster BLX-155 at the International Society on Thrombosis and Haemostasis Meeting
|
|
13 Jul 2007 |
Lab International announces positive results from its Growth Hormone Releasing Hormone (GHRH) Phase II trial
|
|
13 Jul 2007 |
SemBioSys achieves critical Apo AI milestone
|
|
13 Jul 2007 |
Bayer HealthCare Reports Positive Preclinical Study Results on Longer-Acting Recombinant Factor VIII Molecules
|
|
11 Jul 2007 |
Protox announces positive clinical data from prostate cancer study
|
|
11 Jul 2007 |
Sinobiomed Updates on Clincial Trial Progress for Recombinant Batroxobin (rBAT)
|
|
11 Jul 2007 |
CardioVascular BioTherapeutics Authorized to Initiate Phase II Trial of Angiogenesis Therapy for Severe Coronary Heart Disease
|
